StockClub
EVFMEvofem Biosciences, Inc.$ --
Evofem Biosciences, Inc.

Evofem Biosciences, Inc.

EVFM

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 12/31/2025FY2025 Q4
Revenue
10M USD
YoY +34.6%
Operating Income
3M USD
YoY +433.5%
Net Income
3M USD
YoY +191.8%
EPS
0.02$
YoY +169.8%

Revenue

$20.2M
FY2024 Q1$3.6M
$3.6M
Q1
FY2024 Q2$7.8M
$7.8M
Q2
FY2024 Q3$12.3M
$12.3M
Q3
FY2024 Q4$19.4M
$19.4M
Q4
FY2025 Q1$845,000
$845,000
Q1
FY2025 Q2$5.7M
$5.7M
Q2
FY2025 Q3$10.6M
$10.6M
Q3
FY2025 Q4$20.2M
$20.2M
Q4
Actual
+$820,000 (+4.2%)

Net Income

$391,000
FY2024 Q1$-4.8M
$-4.8M
Q1
FY2024 Q2$-3.5M
$-3.5M
Q2
FY2024 Q3$-5.8M
$-5.8M
Q3
FY2024 Q4$-8.9M
$-8.9M
Q4
FY2025 Q1$956,000
$956,000
Q1
FY2025 Q2$-828,000
$-828,000
Q2
FY2025 Q3$-2.4M
$-2.4M
Q3
FY2025 Q4$391,000
$391,000
Q4
Actual
+$9.3M (+104.4%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020MISS
Actual:$446,000
Est:$1.9M
FY2020MISS
$446,000
FY2021BEAT
Actual:$8.2M
Est:$8.1M
FY2021BEAT
$8.2M
FY2022MISS
Actual:$16.8M
Est:$33.2M
FY2022MISS
$16.8M
FY2023MISS
Actual:$18.2M
Est:$18.6M
FY2023MISS
$18.2M
FY2024MISS
Actual:$19.4M
Est:$124.8M
FY2024MISS
$19.4M
FY2025MISS
Actual:$20.2M
Est:$193.3M
FY2025MISS
$20.2M

Analyst Estimates